Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long Covid

Social Shareables

Educate your personal community about ME/CFS, Fibromyalgia, Long COVID, and Lyme disease!
Right-click on each image to download and share on social media. Scroll down to find messages to copy, paste, and share alongside these graphics.

Copy or Tweet the text below!

Over 20 million people have #MECFS worldwide, 25% of whom are homebound & bedbound indefinitely. There are no treatments or cures. It's time for change. Learn more and join the cause to #EndMECFS by donating to support research today: www.omf.ngo

Did you know an estimated 2 million individuals live with Post Treatment #LymeDisease Syndrome? Some patients get better over time, but that may take years. 10-20% of antibiotic-treated Lyme patients remain ill indefinitely. Learn more: https://www.omf.ngo/what-is-lyme-disease/

Did you know an estimated one in four patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) are housebound or bedbound? Despite the severity of this disease, there are no diagnostic tests or treatments. Learn more about #MECFS: www.omf.ngo/what-is-mecfs/

Did you know 4 million people live with #Fibromyalgia in the U.S. alone? Fibromyalgia pain is debilitating and affects every aspect of life, yet there are no treatments or cures. Learn more & find ways to help: https://www.omf.ngo/what-is-fibromyalgia/

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex multi-system disease with many debilitating symptoms. One of the most common symptoms is post-exertional malaise (worsening of symptoms upon even minimal exertion). Learn more: www.omf.ngo/what-is-mecfs/

Anywhere from 25% to 35% of people fail to recover from #COVID19, and are left with debilitating symptoms. A percentage of those who do not recover may end up with #MECFS. Please help fund research into #LongCOVID so we can find answers & a cure: www.omf.ngo

Encourage your social network to support research by donating today:

Please join me in supporting @OpenMedF's quest to find effective treatments and diagnostic tests for the millions of people affected by #MECFS, #Fibromyalgia, #LongCOVID, and related chronic diseases. Learn more or donate today: www.omf.ngo

.@openmedf’s guiding strategy focuses on collaborative research so that precise diagnostic tools & life-changing treatments can be available to people with #MECFS and related chronic complex diseases as soon as possible. Please join me in donating today: www.omf.ngo

Be sure to follow and tag OMF on social media when you post social shareables!

 

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

Averting a second pandemic:

Open Medicine Foundation leads groundbreaking international study of

Long COVID’s conversion to ME/CFS

AGOURA HILLS, CALIF.  — Open Medicine Foundation (OMF) is leading a large-scale international collaborative study investigating the potential conversion of Post-Acute Sequelae SARS-CoV-2 infection — more commonly known as Long COVID or Post-COVID Syndrome —  to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a chronic, life-altering disease with no known cause, diagnostic test or FDA approved treatments available.

Up to 2.5 million people in the U.S. alone suffer from ME/CFS; the COVID-19 pandemic could at least double that number. An estimated 35 percent of Americans who had COVID-19 have failed to fully recover several months after infection, prompting many to call it “a potential second pandemic.”

OMF recognized a familiar health crisis emerging, one with eerie similarities to ME/CFS. This crisis presented a unique opportunity to understand how a viral infection — in this case COVID-19 — may develop into ME/CFS in some patients. The goal is to find targeted treatments for ME/CFS patients and ultimately prevent its onset in people infected with SARS-CoV-2 or other infections.

The federal government is only now investing in Post-COVID research, with no focus on its connection to ME/CFS. OMF has already engaged researchers for the largest-scale study of its kind, solely supported by private donors who have contributed over one million dollars to date. When fully funded, the five million dollar, three-year study will be conducted across the globe at OMF funded Collaborative Research Centers, led by some of the world’s top researchers and ME/CFS experts.

BACKGROUND

In a significant percentage of patients, infections preceded their development of ME/CFS.  For example, according to the CDC about one in ten infected with Epstein-Barr virus, Ross River virus, or Coxiella burnetti develop symptoms that meet the criteria for ME/CFS.

THE STUDY

The ability to follow the development of ME/CFS from a known viral infection is unprecedented to date and crucial to researchers’ understanding of the disease. The focus of this study is to find the biological differences between persons returning to good health after COVID-19 and persons who remained ill more than six months after infection and developed ME/CFS.  Understanding these alterations in key pathways can lead to groundbreaking discoveries including new biomarkers, drug targets, and prevention and treatment strategies.

###

About Open Medicine Foundation

Established in 2012, Open Medicine Foundation leads the largest, concerted worldwide nonprofit effort to diagnose, treat, and prevent ME/CFS and related chronic, complex diseases such as Post Treatment Lyme Disease Syndrome, Fibromyalgia, and Post COVID. OMF adds urgency to the search for answers by driving transformational philanthropy into global research. We have raised over $28 Million from private donors and facilitated and funded the establishment of six prestigious ME/CFS Collaborative Research Centers around the world. To learn more, visit www.omf.ngo.

CONTACT:

Heather Ah San

Development and Communications Manager

1-650-242-8669

heather@omf.ngo